Featured article
How Immunotherapy Is Reshaping DLBCL Care
Diffuse large B-cell lymphoma (DLBCL) remains one of the most common and clinically diverse forms of non-Hodgkin lymphoma.
Read article →Featured articles
Featured article
Can AI Sharpen DLBCL Risk Prediction?
Risk assessment plays an important role in the management of diffuse large B-cell lymphoma, yet traditional clinical scoring systems do not capture the full biological complexity of the disease.
Read article →
Meeting preview
ASH 2026: Preparing for the annual meeting in New Orleans
The 68th ASH Annual Meeting and Exposition, taking place December 12–15, 2026, in New Orleans and online, brings together new research spanning malignant and classical hematology.
Read article →
Clinical perspective
Reading a hematology trial: Start with the study population
A short framework for interpreting research reports before applying their conclusions to clinical practice.
Read article →